Chromosome Microarray (CMA) Detection - CapitalBio Technology Co., Ltd.

Testing Content

Detection of 23 pairs of chromosomal aneuploidy and whole genome chromosomal abnormalities greater than 100kb.

Testing Method

Sample Requirements

Venous Blood: Collect 4mL, store at 2-8°C. Transport with biological ice packs (2-8°C) within 72 hours. Use an EDTA anticoagulant tube.

Reporting Cycle

10 working days

Clinical Application Overview

1. Chromosomal Abnormalities Screening: Screen for chromosomal abnormalities in children with developmental issues, intellectual disabilities, multiple malformations, and other illnesses. Provide guidance for disease confirmation and treatment.

2. Genetic Causes Identification: Identify genetic causes of recurrent miscarriage and infertility. Offer follow-up fertility guidance and recommendations.

PREV: Chromosome Microarray (CMA) Detection (3)

NEXT: Chromosome Microarray (CMA&STR) Detection 2.0

Related IVD Products

Related News Of IVD Technology

CapitalBio's Microarray Scanners: The Precision Eye in BiotechnologyMay 22, 2024The rapid development of biotechnology has made microarray technology an important tool in life science research. CapitalBio's microarray scanners have become a leader in this field due to its exc...view
Unveiling the Immune Fingerprint: Exploring HLA Typing with CapitalBioFebruary 8, 2024Human leukocyte antigen (HLA) typing, also known as HLA genotyping, unlocks a wealth of information about an individual's immune system. These unique molecules, expressed on the surface of cells, ...view
Exploring the Advantages and Limitations of Shotgun Metagenomics: A Comprehensive Overview by CapitalBio TechnologyJuly 2, 2024In the rapidly evolving field of microbiology, the ability to comprehensively analyze microbial communities has become increasingly important. CapitalBio Technology, a leader in metagenomics sequencin...view
What Are the Main Processes of DNA Microarray Technology?March 8, 2023The principle of DNA microarray technology is to integrate gene probes with known sequences onto a solid surface. A large number of labeled nucleic acid sequences from the tested biological cells or t...view
Caution! Streptococcus Pneumoniae Disease Has Become the Second Leading Cause of Death Among Children Under 5August 31, 2023Pneumonia affects people's health globally and is a common respiratory system infectious disease. It is also a significant cause of death in children worldwide due to infection. Streptococcus pneu...view
CapitalBio and Fetal Chromosomal Aneuploidy: Cutting-edge Exploration and Technological InnovationMay 22, 2024CapitalBio is one of the leading companies in China's biotechnology field. With strong scientific research strength and technological innovation, CapitalBio has rapidly developed into a leading in...view